Results 81 to 90 of about 28,464 (119)

miRNA-dependent resistance mechanisms to anti-hormonal therapies in estrogen receptor-positive breast cancer patients. [PDF]

Mol Ther Oncol
Al Hashami ZS, van der Vegt B, Mourits MJE, Kluiver J, van den Berg A.   +4 more
europepmc   +1 more source

Recent updates of centromere proteins in hepatocellular carcinoma: a review. [PDF]

Infect Agent Cancer
Yang Z, Chen W, Liu Y, Niu Y.
europepmc   +1 more source

Bladder cancer biomarkers. [PDF]

Explor Target Antitumor Ther
Godlewski D, Bartusik-Aebisher D, Czech S, Szpara J, Aebisher D.   +4 more
europepmc   +1 more source

Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. [PDF]

JCO Precis Oncol, 2023
Gerratana L, Davis AA, Velimirovic M, Reduzzi C, Clifton K, Bucheit L, Hensing WL, Shah AN, Pivetta T, Dai CS, D'Amico P, Wehbe F, Medford A, Wander SA, Gradishar WJ, Behdad A, Ma CX, Puglisi F, Bardia A, Cristofanilli M.   +19 more
europepmc   +1 more source

Recent Advances in the Clinical Translation of Small-Cell Lung Cancer Therapeutics. [PDF]

Cancers (Basel)
Das S, Samaddar S.
europepmc   +1 more source

Molecular Biological Research on the Pathogenic Mechanism of Retinoblastoma. [PDF]

Curr Issues Mol Biol
Ma X, Li X, Sun Q, Luan F, Feng J.
europepmc   +1 more source

Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target. [PDF]

Int J Mol Sci
Sias F, Zoroddu S, Migheli R, Bagella L.
europepmc   +1 more source

Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities. [PDF]

Exp Hematol Oncol
Zhang J, Zeng X, Guo Q, Sheng Z, Chen Y, Wan S, Zhang L, Zhang P.   +7 more
europepmc   +1 more source

PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma. [PDF]

BJC Rep
Pan M, Zhou MY, Jiang C, Zhang Z, Bui N, Bien J, Siy A, Achacoso N, Solorzano AV, Tse P, Chung E, Hu W, Thomas S, Ganjoo K, Habel LA.   +14 more
europepmc   +1 more source